About the Event
Spire Health has developed a state-of-the-art wearable device that monitors a COPD patient’s respiration while being completely unobtrusive and portable, leading to 94% compliance by the user.
COPD affects more than 15 million Americans and worldwide is the third leading cause of death. Spire Health’s Health Tag sensor has set out to change the patient journey by continuous monitoring of COPD patients’ expansion and contraction of the lungs, which allows early detection of breathing exacerbations by the proprietary algorithm that may otherwise go undetected until it’s too late. With the help of their physician, patients can correct issues with early outpatient intervention rather than intrusive and costly hospitalizations. In fact it reduces hospitalizations 65% and saves payers $10,000 per member annually.
Join our webinar with Spire’s Health CEO, Mike Doyle to hear why they already have 3,400 patients using their FDA-Approved technology today and have attracted the interest of major health organizations such as Kaiser Permanente and Asaar Medical.